Form EFFECT AMICUS THERAPEUTICS,
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | April 29, 2026 |
| Accession Number: | 0001140361-26-016986 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- ERI Co-Founders Share Insights on the Future of Mobility Technology Circularity at Mobile Disrupt 2026 Conference
- Sigma Lithium Produced 35,000t Lithium Concentrate in 2Q26, Beat Guidance, Delivering Successful Mining Operations Upgrade
- IFF to Release Second Quarter 2026 Results on August 4, 2026
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
